BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 33000203)

  • 21. Abnormal expression of HAX‑1 is associated with cellular proliferation and migration in human hypopharyngeal squamous cell carcinoma.
    Wu H; Chen J; Wang Q; Yin Y; Da P; Le H; Zhang Z; Qiu X
    Mol Med Rep; 2017 Oct; 16(4):4664-4670. PubMed ID: 28791389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxygenkwanin suppresses proliferation, invasion and migration of osteosarcoma cells via the miR‑320a/SOX9 axis.
    Dong X; Wang Y; Zhuang H; An G
    Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35929504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of miR-99b in mediating hepatocellular carcinoma invasion and migration.
    Liu CJ; Yang JH; Huang FZ; Yang JH; Liu CP; Mao XH; Yi WM; Shen XB; Peng C; Chen MF; Jiang B; Wu JS
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2273-2281. PubMed ID: 29762829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA‑590 inhibits migration, invasion and epithelial‑to‑mesenchymal transition of esophageal squamous cell carcinoma by targeting low‑density lipoprotein receptor‑related protein 6.
    Guan H; Liu J; Lv P; Zhou L; Zhang J; Cao W
    Oncol Rep; 2020 Oct; 44(4):1385-1392. PubMed ID: 32945478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
    Wang G; Fang X; Han M; Wang X; Huang Q
    Int J Mol Med; 2018 Mar; 41(3):1740-1748. PubMed ID: 29328362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-9-3p regulates the biological functions and drug resistance of gemcitabine-treated breast cancer cells and affects tumor growth through targeting MTDH.
    Wang Y; Dong L; Wan F; Chen F; Liu D; Chen D; Long J
    Cell Death Dis; 2021 Sep; 12(10):861. PubMed ID: 34552061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-126-5p downregulates BCAR3 expression to promote cell migration and invasion in endometriosis.
    Meng X; Liu J; Wang H; Chen P; Wang D
    Mol Cell Endocrinol; 2019 Aug; 494():110486. PubMed ID: 31233772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
    Hong X; Yu JJ
    Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catalpol inhibits the proliferation, migration and metastasis of HCC cells by regulating miR‑140‑5p expression.
    Wu L; Li H; Chen S; Wu X; Chen X; Wang F
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
    Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
    Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
    J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA‑181a promotes epithelial‑mesenchymal transition in esophageal squamous cell carcinoma via the TGF‑β/Smad pathway.
    Xu R; Zhou XM; Li YS; Ren L; He XR
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K
    Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NELFE promoted pancreatic cancer metastasis and the epithelial‑to‑mesenchymal transition by decreasing the stabilization of NDRG2 mRNA.
    Han L; Zan Y; Huang C; Zhang S
    Int J Oncol; 2019 Dec; 55(6):1313-1323. PubMed ID: 31638184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of UPF1 expression on EMT process by targeting E‑cadherin, N‑cadherin, Vimentin and Twist in a hepatocellular carcinoma cell line.
    Li Y; Zhang T; Qin S; Wang R; Li Y; Zhou Z; Chen Y; Wu Q; Su F
    Mol Med Rep; 2019 Mar; 19(3):2137-2143. PubMed ID: 30628676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. microRNA-145 modulates epithelial-mesenchymal transition and suppresses proliferation, migration and invasion by targeting SIP1 in human cervical cancer cells.
    Sathyanarayanan A; Chandrasekaran KS; Karunagaran D
    Cell Oncol (Dordr); 2017 Apr; 40(2):119-131. PubMed ID: 27933466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA‑214 suppresses the viability, migration and invasion of human colorectal carcinoma cells via targeting transglutaminase 2.
    Shan H; Zhou X; Chen C
    Mol Med Rep; 2019 Aug; 20(2):1459-1467. PubMed ID: 31173203
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.